These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9747055)

  • 1. Hepatitis C: caution up ahead.
    D'Alonzo GE; Oliveri EA
    J Am Osteopath Assoc; 1998 Aug; 98(8):431-2. PubMed ID: 9747055
    [No Abstract]   [Full Text] [Related]  

  • 2. New treatment for hepatitis C.
    Williams CN
    Can J Gastroenterol; 1999; 13(1):19-20. PubMed ID: 10099812
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon therapy for chronic hepatitis C.
    Davis GL
    Baillieres Clin Gastroenterol; 1996 Jul; 10(2):289-98. PubMed ID: 8864035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy in chronic hepatitis C: say goodbye to the 6-month interferon regimen.
    Koff RS
    Am J Gastroenterol; 1996 Oct; 91(10):2072-4. PubMed ID: 8855723
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C. New treatment helps some, but cure remains elusive.
    Henkel J
    FDA Consum; 1999; 33(2):23-9. PubMed ID: 10214120
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C. The point of view of a clinical anaesthetist and intensive care specialist].
    Metzler H
    Anaesthesist; 2003 May; 52(5):453-5. PubMed ID: 12750830
    [No Abstract]   [Full Text] [Related]  

  • 7. Breakthrough of interferon therapy.
    Scalori A; Ricci A; Bellati G; Colloredo G; Roffi L
    Am J Gastroenterol; 1996 Oct; 91(10):2249-50. PubMed ID: 8855768
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 9. Why we should treat chronic viral hepatitis.
    King PD
    Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C infection: a review.
    Feng X
    Lippincotts Prim Care Pract; 1999; 3(3):345-53. PubMed ID: 10711135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C. Understanding the issues.
    Miller SK
    Adv Nurse Pract; 2000 Dec; 8(12):49-50, 87-8. PubMed ID: 12397910
    [No Abstract]   [Full Text] [Related]  

  • 12. A rational approach to hepatitis C.
    Mills P; McPeake J; McCruden E
    Practitioner; 1996 Mar; 240(1560):172-6. PubMed ID: 8710731
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of human leukocyte alpha interferon on cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
    Gilli P; Stabellini N; Storari A; Gualandi G; Guerra G; Ghinelli F
    Nephrol Dial Transplant; 1996 Mar; 11(3):526-8. PubMed ID: 8671825
    [No Abstract]   [Full Text] [Related]  

  • 14. [Consensus interferon: a new weapon in the treatment of chronic hepatitis C].
    Vespasiani Gentilucci U; Picardi A
    Clin Ter; 2000; 151(3):211-2. PubMed ID: 10958058
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-alpha in hepatitis C. Dosage, costs and benefits.
    Briggs A; Shiell A
    Pharmacoeconomics; 1996 Sep; 10(3):205-9. PubMed ID: 10163569
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C in children.
    Sehgal S; Jackson Allen PL
    Pediatr Nurs; 2004; 30(5):409-13. PubMed ID: 15587536
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
    Khan HA; Khawaja FI; Mahrous AR
    Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB; Hollinger FB
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
    Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
    Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infergen (interferon alfacon-1).
    Gastroenterol Nurs; 1998; 21(1):30-1. PubMed ID: 9555366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.